Mathematical Modelling of Polyamine Metabolism in Bloodstream-Form Trypanosoma brucei: An Application to Drug Target Identification

We present the first computational kinetic model of polyamine metabolism in bloodstream-form Trypanosoma brucei, the causative agent of human African trypanosomiasis. We systematically extracted the polyamine pathway from the complete metabolic network while still maintaining the predictive capability of the pathway. The kinetic model is constructed on the basis of information gleaned from the experimental biology literature and defined as a set of ordinary differential equations. We applied Michaelis-Menten kinetics featuring regulatory factors to describe enzymatic activities that are well defined. Uncharacterised enzyme kinetics were approximated and justified with available physiological properties of the system. Optimisation-based dynamic simulations were performed to train the model with experimental data and inconsistent predictions prompted an iterative procedure of model refinement. Good agreement between simulation results and measured data reported in various experimental conditions shows that the model has good applicability in spite of there being gaps in the required data. With this kinetic model, the relative importance of the individual pathway enzymes was assessed. We observed that, at low-to-moderate levels of inhibition, enzymes catalysing reactions of de novo AdoMet (MAT) and ornithine production (OrnPt) have more efficient inhibitory effect on total trypanothione content in comparison to other enzymes in the pathway. In our model, prozyme and TSHSyn (the production catalyst of total trypanothione) were also found to exhibit potent control on total trypanothione content but only when they were strongly inhibited. Different chemotherapeutic strategies against T. brucei were investigated using this model and interruption of polyamine synthesis via joint inhibition of MAT or OrnPt together with other polyamine enzymes was identified as an optimal therapeutic strategy.

[1]  Biao Huang,et al.  System Identification , 2000, Control Theory for Physicists.

[2]  R. Moreno-Sánchez,et al.  Drug target validation of the trypanothione pathway enzymes through metabolic modelling , 2012, The FEBS journal.

[3]  Michael P. Barrett,et al.  Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei , 2012, PLoS neglected tropical diseases.

[4]  Lennart Ljung,et al.  Perspectives on system identification , 2010, Annu. Rev. Control..

[5]  M. Phillips,et al.  RNA Interference-Mediated Silencing of Ornithine Decarboxylase and Spermidine Synthase Genes in Trypanosoma brucei Provides Insight into Regulation of Polyamine Biosynthesis , 2009, Eukaryotic Cell.

[6]  M. Phillips,et al.  Regulated Expression of an Essential Allosteric Activator of Polyamine Biosynthesis in African Trypanosomes , 2008, PLoS pathogens.

[7]  A. Fairlamb,et al.  Leishmania Trypanothione Synthetase-Amidase Structure Reveals a Basis for Regulation of Conflicting Synthetic and Hydrolytic Activities*S⃞ , 2008, Journal of Biological Chemistry.

[8]  N. Gow,et al.  Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins , 2008, PLoS pathogens.

[9]  H. Kaur,et al.  Validation of spermidine synthase as a drug target in African trypanosomes. , 2008, The Biochemical journal.

[10]  L. Manderson,et al.  Community and School-Based Health Education for Dengue Control in Rural Cambodia: A Process Evaluation , 2007, PLoS neglected tropical diseases.

[11]  F. Checchi,et al.  Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series , 2007, PLoS neglected tropical diseases.

[12]  J. Sufrin,et al.  Novel Trypanocidal Analogs of 5′-(Methylthio)-Adenosine , 2007, Antimicrobial Agents and Chemotherapy.

[13]  O. Heby,et al.  Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis , 2007, Amino Acids.

[14]  M. Phillips,et al.  Allosteric regulation of an essential trypanosome polyamine biosynthetic enzyme by a catalytically dead homolog , 2007, Proceedings of the National Academy of Sciences.

[15]  Y. Pérez-Pertejo,et al.  S-Adenosylmethionine in protozoan parasites: functions, synthesis and regulation. , 2007, Molecular and biochemical parasitology.

[16]  Natal A. W. van Riel,et al.  Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments , 2006, Briefings Bioinform..

[17]  F. Checchi,et al.  Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda , 2006, PLoS clinical trials.

[18]  Eduardo Sontag,et al.  Parameter estimation in models combining signal transduction and metabolic pathways: the dependent input approach. , 2006, Systems biology.

[19]  Marta Cascante,et al.  Mathematical Modeling of Polyamine Metabolism in Mammals* , 2006, Journal of Biological Chemistry.

[20]  M. Phillips,et al.  Mechanisms of allosteric regulation of Trypanosoma cruzi S-adenosylmethionine decarboxylase. , 2006, Biochemistry.

[21]  Eduardo Sontag Some Remarks on Input Choices for Biochemical Systems , 2006, math/0606261.

[22]  M. Bots,et al.  Effect of Folic Acid and Betaine Supplementation on Flow-Mediated Dilation: A Randomized, Controlled Study in Healthy Volunteers , 2006, PLoS clinical trials.

[23]  N. V. van Riel Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments. , 2006, Briefings in bioinformatics.

[24]  A. Fairlamb,et al.  Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome. , 2005, The Biochemical journal.

[25]  J. Turrens Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa. , 2004, Molecular aspects of medicine.

[26]  A. Fairlamb,et al.  Properties of trypanothione synthetase from Trypanosoma brucei. , 2003, Molecular and biochemical parasitology.

[27]  Eva Liebau,et al.  Thiol-based redox metabolism of protozoan parasites. , 2003, Trends in parasitology.

[28]  C. Kahana,et al.  Putrescine activates oxidative stress dependent apoptotic death in ornithine decarboxylase overproducing mouse myeloma cells. , 2002, Experimental cell research.

[29]  A. Fairlamb,et al.  Characterization of recombinant glutathionylspermidine synthetase/amidase from Crithidia fasciculata. , 2002, The Biochemical journal.

[30]  H. Kitano Systems Biology: A Brief Overview , 2002, Science.

[31]  A. Fairlamb,et al.  Ovothiol and trypanothione as antioxidants in trypanosomatids. , 2001, Molecular and biochemical parasitology.

[32]  Eberhard O. Voit,et al.  Computational Analysis of Biochemical Systems: A Practical Guide for Biochemists and Molecular Biologists , 2000 .

[33]  D. Lloyd,et al.  Kinetics of methionine transport and metabolism by Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense. , 2000, Archives of biochemistry and biophysics.

[34]  Barbara M. Bakker,et al.  Control and regulation of glycolysis in Trypanosoma brucei , 1998 .

[35]  Lennart Ljung Some Aspects of Nonlinear Black-Box Modeling in System Identification , 1997 .

[36]  S. Croft,et al.  In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors , 1996, Antimicrobial agents and chemotherapy.

[37]  B. Berger,et al.  Aromatic amino acid transamination and methionine recycling in trypanosomatids. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Meshnick,et al.  Methionine recycling pathways and antimalarial drug design , 1995, Antimicrobial agents and chemotherapy.

[39]  N. Yarlett,et al.  Fate of soluble methionine in African trypanosomes: effects of metabolic inhibitors. , 1995, The Biochemical journal.

[40]  Y. Murakami,et al.  Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Sufrin,et al.  S-adenosylmethionine synthetase in bloodstream Trypanosoma brucei. , 1993, Biochimica et biophysica acta.

[42]  J. Sufrin,et al.  5'-Alkyl-substituted analogs of 5'-methylthioadenosine as trypanocides , 1991, Antimicrobial Agents and Chemotherapy.

[43]  N. Yarlett,et al.  Protein methylases in Trypanosoma brucei brucei: activities and response to DL-alpha-difluoromethylornithine. , 1991, Journal of general microbiology.

[44]  A. Bitonti,et al.  Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase , 1990, Antimicrobial Agents and Chemotherapy.

[45]  J. Fitchen,et al.  Methionine recycling as a target for antiprotozoal drug development. , 1989, Parasitology today.

[46]  L. Christa,et al.  Methylthioadenosine toxicity and metabolism to methionine in mammalian cells. , 1988, The Biochemical journal.

[47]  L. Ghoda,et al.  Substrate specificities of 5'-deoxy-5'-methylthioadenosine phosphorylase from Trypanosoma brucei brucei and mammalian cells. , 1988, Molecular and biochemical parasitology.

[48]  N. Yarlett,et al.  Effect of dl-α-difluoromethylornithine on methionine cycle intermediates in Trypanosoma brucei brucei , 1988 .

[49]  A. Fairlamb,et al.  Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei. , 1987, Molecular and biochemical parasitology.

[50]  A. Fairlamb,et al.  In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. , 1987, Molecular and biochemical parasitology.

[51]  P. McCann,et al.  Effects of DL-alpha-difluoromethylornithine on Leishmania donovani promastigotes. , 1986, The Journal of protozoology.

[52]  C. Porter,et al.  Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. , 1986, Anticancer research.

[53]  G. Cross,et al.  Cysteine eliminates the feeder cell requirement for cultivation of Trypanosoma brucei bloodstream forms in vitro , 1985, The Journal of experimental medicine.

[54]  A. Bitonti,et al.  Characterization of spermidine synthase from Trypanosoma brucei brucei. , 1984, Molecular and biochemical parasitology.

[55]  A. Pegg,et al.  Comparison of inhibitors of S-adenosylmethionine decarboxylase from different species. , 1983, The Biochemical journal.

[56]  R. Smith,et al.  Identification of 2-keto-4-methylthiobutyrate as an intermediate compound in methionine synthesis from 5'-methylthioadenosine. , 1982, The Journal of biological chemistry.

[57]  P. McCann,et al.  Polyamine metabolism: a potential therapeutic target in trypanosomes. , 1980, Science.

[58]  R. Iyengar,et al.  A two-state model of an enzyme with an allosteric regulatory site capable of metabolizing the regulatory ligand. Simplified mathematical treatments of transient and steady state kinetics of an activator and its competitive inhibition as applied to adenylyl cyclases. , 1980, The Journal of biological chemistry.